UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence

The European respiratory journal, 2017-11, Vol.50 (5), p.1701462-1701462

2017

Link zum Volltext

Verfügbarkeit prüfen

Multidrug-resistant tuberculosis and beyond: an updated analysis of the current evidence on bedaquiline

The European respiratory journal, 2017-03, Vol.49 (3), p.1700146-1700146

2017

Link zum Volltext

Verfügbarkeit prüfen

Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review

The European respiratory journal, 2018-07, Vol.52 (1), p.1800934-1800934

2018

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study

The European respiratory journal, 2017-05, Vol.49 (5), p.1700387-1700387

2017

Link zum Volltext

Verfügbarkeit prüfen

Drug resistant TB – latest developments in epidemiology, diagnostics and management

International journal of infectious diseases, 2022-11, Vol.124, p.S20-S25

2022

Link zum Volltext

Verfügbarkeit prüfen

MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network

International journal of infectious diseases, 2020-03, Vol.92, p.S15-S25

2020

Link zum Volltext

Verfügbarkeit prüfen

Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review

International journal of molecular sciences, 2016-03, Vol.17 (3), p.373-373

2016

Link zum Volltext

Verfügbarkeit prüfen

The definition of tuberculosis infection based on the spectrum of tuberculosis disease

Breathe (Lausanne, Switzerland), 2021-09, Vol.17 (3), p.210079-210079

2021

Link zum Volltext

Verfügbarkeit prüfen

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients

PLoS medicine, 2012-08, Vol.9 (8), p.e1001300

2012

Link zum Volltext

Verfügbarkeit prüfen

Post-tuberculosis sequelae and their socioeconomic consequences: worth investigating

The Lancet global health, 2021-12, Vol.9 (12), p.e1628-e1629

2021

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis treatment and management—an update on treatment regimens, trials, new drugs, and adjunct therapies

The lancet respiratory medicine, 2015-03, Vol.3 (3), p.220-234

2015

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis elimination: where are we now?

European respiratory review, 2018-06, Vol.27 (148), p.180035

2018

Link zum Volltext

Verfügbarkeit prüfen

Post tuberculosis treatment infectious complications

International journal of infectious diseases, 2020-03, Vol.92, p.S41-S45

2020

Link zum Volltext

Verfügbarkeit prüfen

Amikacin liposome and Mycobacterium avium complex: A systematic review

PloS one, 2022-12, Vol.17 (12), p.e0279714

2022

Link zum Volltext

Verfügbarkeit prüfen

Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review

International journal of molecular sciences, 2017-02, Vol.18 (2), p.341-341

2017

Link zum Volltext

Verfügbarkeit prüfen

ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update

The European respiratory journal, 2018-05, Vol.51 (5), p.1702678-1702678

2018

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and safety of clofazimine in multidrug-resistant tuberculosis: a nationwide report from Brazil

The European respiratory journal, 2017-03, Vol.49 (3), p.1602445-1602445

2017

Link zum Volltext

Verfügbarkeit prüfen

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis

Emerging infectious diseases, 2017-10, Vol.23 (10), p.1718-1721

2017

Link zum Volltext

Verfügbarkeit prüfen

Shifting from tuberculosis control to elimination: Where are we? What are the variables and limitations? Is it achievable?

International journal of infectious diseases, 2017-03, Vol.56 (C), p.30-33

2017

Link zum Volltext

Verfügbarkeit prüfen

Brittle Asthma: Still on Board?

Biomedicines, 2023-11, Vol.11 (11), p.3086

2023

Link zum Volltext

Verfügbarkeit prüfen

Classifying new anti-tuberculosis drugs: rationale and future perspectives

International journal of infectious diseases, 2017-03, Vol.56 (C), p.181-184

2017

Link zum Volltext

Verfügbarkeit prüfen

Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis

International journal of infectious diseases, 2022-11, Vol.124 (Suppl 1), p.S90-S103

2022

Link zum Volltext

Verfügbarkeit prüfen

Resistance profile of drugs composing the "shorter" regimen for multidrug-resistant tuberculosis in Brazil, 2000-2015

The European respiratory journal, 2017-04, Vol.49 (4), p.1602309-1602309

2017

Link zum Volltext

Verfügbarkeit prüfen

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

International journal of infectious diseases, 2019-06, Vol.83, p.72-76

2019

Link zum Volltext

Verfügbarkeit prüfen

New anti-tuberculosis drugs and regimens: 2015 update

ERJ open research, 2015-05, Vol.1 (1), p.10

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 187

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(170)
Mit Volltextzugriff
(175)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(148)
Life Sciences & Biomedicine
(146)
Humans
(116)
Respiratory System
(94)
Tuberculosis
(67)
Antitubercular Agents - Therapeutic Use
(49)
Tuberculosis, Multidrug-Resistant - Drug Therapy
(48)
Infectious Diseases
(45)
Male
(40)
Extensively Drug-Resistant Tuberculosis - Drug Therapy
(36)
Female
(34)
Mycobacterium
(27)
Adult
(25)
World Health Organization
(25)
Treatment Outcome
(22)
Drug Resistance
(18)
Mdr-Tb
(18)
Tuberculosis - Epidemiology
(18)
Tuberculosis - Prevention & Control
(18)
Mycobacterium Tuberculosis - Drug Effects
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence

Multidrug-resistant tuberculosis and beyond: an updated analysis of the current evidence on bedaquiline

Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study

Drug resistant TB – latest developments in epidemiology, diagnostics and management

MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network

Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review

The definition of tuberculosis infection based on the spectrum of tuberculosis disease

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients

Post-tuberculosis sequelae and their socioeconomic consequences: worth investigating

Tuberculosis treatment and management—an update on treatment regimens, trials, new drugs, and adjunct therapies

Tuberculosis elimination: where are we now?

Post tuberculosis treatment infectious complications

Amikacin liposome and Mycobacterium avium complex: A systematic review

Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review

ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update

Effectiveness and safety of clofazimine in multidrug-resistant tuberculosis: a nationwide report from Brazil

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis

Shifting from tuberculosis control to elimination: Where are we? What are the variables and limitations? Is it achievable?

Brittle Asthma: Still on Board?

Classifying new anti-tuberculosis drugs: rationale and future perspectives

Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis

Resistance profile of drugs composing the "shorter" regimen for multidrug-resistant tuberculosis in Brazil, 2000-2015

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

New anti-tuberculosis drugs and regimens: 2015 update

Suchergebnisse filtern